日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum: Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models

更正:ABTL0812(一种临床阶段药物,可诱导自噬介导的癌细胞死亡)在胶质母细胞瘤模型中的抗癌作用

Mancini, Andrea; Colapietro, Alessandro; Cristiano, Loredana; Rossetti, Alessandra; Mattei, Vincenzo; Gravina, Giovanni Luca; Perez-Montoyo, Héctor; Yeste-Velasco, Marc; Alfon, Jose; Domenech, Carles; Festuccia, Claudio

Visualization of renal rotenone accumulation after oral administration and in situ detection of kidney injury biomarkers via MALDI mass spectrometry imaging

利用基质辅助激光解吸电离质谱成像技术,可视化口服给药后肾脏中鱼藤酮的积累情况,并原位检测肾损伤生物标志物。

Tenebro, Chuckcris P; Marcial, Neaven Bon Joy M; Salcepuedes, Janine J; Torrecampo, Josie C; Hernandez, Rajelle D; Francisco, John Alfon P; Infante, Kristine Mae G; Belardo, Veronica J; Paderes, Monissa C; Alvero, Rita Grace Y; Saludes, Jonel P; Dalisay, Doralyn S

ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

ENDOLUNG试验。一项针对晚期/复发性子宫内膜癌患者的1/2期研究,旨在评估Akt/mTOR抑制剂和自噬诱导剂Ibrilatazar(ABTL0812)联合紫杉醇/卡铂的疗效。

Leary, Alexandra; Estévez-García, Purificación; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina-Ginesta, Pilar; Gil-Martin, Marta; Garralda, Elena; Bosch-Barrera, Joaquim; Morán, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascón, Pere; Rodon, Jordi; Lizcano, Jose M; Muñoz-Guardiola, Pau; Fierro-Durán, Gemma; Pedrós-Gámez, Oriol; Pérez-Montoyo, Héctor; Yeste-Velasco, Marc; Cortal, Marc; Pérez-Campos, Antonio; Alfon, Jose; Domenech, Carles; Pérez-Fidalgo, Alejandro; Oaknin, Ana

Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer : Alexandra Leary

更正:ENDOLUNG试验。一项评估Akt/mTOR抑制剂和自噬诱导剂Ibrilatazar(ABTL0812)联合紫杉醇/卡铂治疗晚期/复发性子宫内膜癌患者的I/II期临床研究:Alexandra Leary

Leary, Alexandra; Estévez-García, Purificación; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina-Ginesta, Pilar; Gil-Martin, Marta; Garralda, Elena; Bosch-Barrera, Joaquim; Morán, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascón, Pere; Rodon, Jordi; Lizcano, Jose M; Muñoz-Guardiola, Pau; Fierro-Durán, Gemma; Pedrós-Gámez, Oriol; Pérez-Montoyo, Héctor; Yeste-Velasco, Marc; Cortal, Marc; Pérez-Campos, Antonio; Alfon, Jose; Domenech, Carles; Pérez-Fidalgo, Alejandro; Oaknin, Ana

Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models

ABTL0812(一种临床阶段的自噬介导癌细胞死亡的药物诱导剂)在胶质母细胞瘤模型中的抗癌作用

Andrea Mancini, Alessandro Colapietro, Loredana Cristiano, Alessandra Rossetti, Vincenzo Mattei, Giovanni Luca Gravina, Héctor Perez-Montoyo, Marc Yeste-Velasco, Jose Alfon, Carles Domenech, Claudio Festuccia

Audit of Anesthetic Equipment in Veterinary Clinics in Spain and Portugal

西班牙和葡萄牙兽医诊所麻醉设备审计

Redondo, Jose I; Domenech, Luis; Mateu, Cristina; Bañeres, Alfon; Martínez, Amalia; Lopes, Diana

Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

TRIB3介导细胞自噬的新型抗癌药物ABTL0812在子宫内膜癌中的治疗潜力

Isidre Felip, Cristian Pablo Moiola, Cristina Megino-Luque, Carlos Lopez-Gil, Silvia Cabrera, Sonia Solé-Sánchez, Pau Muñoz-Guardiola, Elisabet Megias-Roda, Héctor Pérez-Montoyo, José Alfon, Marc Yeste-Velasco, María Santacana, Xavier Dolcet, Armando Reques, Ana Oaknin, Victor Rodríguez-Freixinos, J